STRUCTURE-PHARMACOKINETIC RELATIONSHIPS IN A SERIES OF SHORT FATTY-ACID AMIDES THAT POSSESS ANTICONVULSANT ACTIVITY

被引:34
作者
HAJYEHIA, A [1 ]
BIALER, M [1 ]
机构
[1] HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,POB 12065,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1002/jps.2600790814
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Valpromide (VPD) and valnoctamide (VCD) are two isomers which are aliphatic amides derived from short fatty acids that possess anticonvulsant activity. Our previous studies with VPD, VCD, and other related compounds showed that the biotransformation of these amides to their respective homologous acids is the key issue in their possessing pharmacological activity. In this study, we explored the structure–pharmacokinetic relationships of the following five isomers or analogues of VPD: diisproprylacetamide (DID), diallylacetamide (DAD), octanamide (OAD), ethylisobutylacetamide (EID), and dimethylbutylacetamide (DBD). In addition, the anticonvulsant activity of these compounds was evaluated and compared with that of VPD and VCD. No plasma levels of OAD could be detected after its iv administration. Octanamide (OAD) was very rapidly metabolized to its homologous acid, octanoic acid (OAA). Octanamide (OAD) was different from the other four amides investigated, having a high clearance (due to metabolic processes in the blood) and possessing the least anticonvulsant activity. All of the other amides were stable in blood and showed similar pharmacokinetic parameters. Unlike the other amides, DID and VCD did not metabolize to their respective homologous acids due to the fact that they had a substituted β position in their aliphatic side chain. Our study showed that, despite similarities in the chemical structures of the amides investigated, significant differences were observed in their pharmacokinetics and in the fraction of the amide (fm) biotransformed to its homologous acid. These differences in fm values may, therefore, account for the observed differences in the respective pharmacological activities, in general, and in the extent of the anticonvulsant activity, in particular, of the amides. In this particular series of aliphatic amides, which were derived from short‐branched fatty acids, the biotransformation of the amide to its homologous acid appeared dependent on the chemical structure, especially on the substitution at the β position of the molecule. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:719 / 724
页数:6
相关论文
共 39 条
[1]  
Altman P. L., 1974, BIOL DATA BOOK, V3, P1702
[2]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[3]   A COMPARATIVE-STUDY ON THE PHARMACOKINETICS OF VALPRAMIDE AFTER INTRAVENOUS ADMINISTRATION IN DOGS [J].
BIALER, M ;
RUBINSTEIN, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (09) :607-609
[4]   PHARMACOKINETICS OF VALPROMIDE AFTER ORAL-ADMINISTRATION OF A SOLUTION AND A TABLET TO HEALTHY-VOLUNTEERS [J].
BIALER, M ;
RUBINSTEIN, A ;
RAZ, I ;
ABRAMSKY, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (04) :501-503
[5]   PHARMACOKINETICS OF VALPROMIDE IN DOGS AFTER VARIOUS MODES OF ADMINISTRATION [J].
BIALER, M ;
RUBINSTEIN, A .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (02) :177-183
[6]   A COMPARATIVE PHARMACOKINETIC STUDY OF VALPROMIDE AND VALPROIC ACID AFTER INTRAVENOUS ADMINISTRATION IN HUMANS [J].
BIALER, M ;
RUBINSTEIN, A ;
DUBROVSKY, J ;
RAZ, I ;
ABRAMSKY, O .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 23 (01) :25-33
[7]   RAPID GAS-CHROMATOGRAPHIC ASSAY FOR MONITORING VALPROIC ACID AND VALPROMIDE IN PLASMA [J].
BIALER, M ;
FRIEDMAN, M ;
RUBINSTEIN, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (07) :991-993
[8]   RAPID GAS-CHROMATOGRAPHIC ASSAY FOR MONITORING VALNOCTAMIDE IN PLASMA [J].
BIALER, M ;
HOCH, B .
JOURNAL OF CHROMATOGRAPHY, 1985, 337 (02) :408-411
[9]  
BILLIG H, IN PRESS DRUG METAB
[10]  
CHAMBON JP, 1980, NEUROSCI LETT S, V5, pS327